Dr. Chin, an oncology specialist, most recently served as senior vice president and head of clinical development at 2Seventy Bio, a biotechnology company, according to a March 1 news release from Marengo.
In his new role, Dr. Chin will manage the development of the company’s clinical portfolio, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
